Detalhe da pesquisa
1.
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
Aliment Pharmacol Ther
; 25(1): 39-46, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17229219
2.
Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
Clin Pharmacol Ther
; 66(2): 140-51, 1999 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10460068
3.
Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.
Aliment Pharmacol Ther
; 14(8): 1057-64, 2000 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10930900
4.
Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Aliment Pharmacol Ther
; 8(6): 603-7, 1994 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-7696449
5.
Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients.
Aliment Pharmacol Ther
; 7(4): 451-7, 1993 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8218759
6.
In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
Aliment Pharmacol Ther
; 10(5): 771-5, 1996 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8899086
7.
Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis.
Aliment Pharmacol Ther
; 13(7): 937-43, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10383529
8.
Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
Aliment Pharmacol Ther
; 12(4): 329-35, 1998 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9690721
9.
Determination of urinary cystine for monitoring anticystinuric therapy.
Clin Chim Acta
; 165(2-3): 351-8, 1987 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-3652456
10.
Glass and antimony electrodes for long-term pH monitoring: a dynamic in vitro comparison.
Eur J Gastroenterol Hepatol
; 7(1): 29-35, 1995 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-7866807
11.
[Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers]. / Intraveneuze remming van de maagzuursecretie bij stressulcera en bloedende peptische ulcera.
Ned Tijdschr Geneeskd
; 143(50): 2514-8, 1999 Dec 11.
Artigo
em Holandês
| MEDLINE | ID: mdl-10627753
12.
Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
Scand J Gastroenterol Suppl
; (232): 10-20, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11232484
13.
Prevention of stress ulcer bleeding: a review.
Scand J Gastroenterol Suppl
; 178: 32-41, 1990.
Artigo
em Inglês
| MEDLINE | ID: mdl-2277967
14.
Pharmacokinetics of ranitidine in a homogeneous population of intensive care unit patients during intermittent and continuous administration.
Scand J Gastroenterol Suppl
; 194: 55-8, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1298048
15.
Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
Scand J Gastroenterol Suppl
; 218: 10-5, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8865445
16.
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.
Aliment Pharmacol Ther
; 31(1): 150-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19785625
17.
Pattern of 72-hour intragastric acidity in a homogeneous group of intensive care unit patients.
Dig Dis Sci
; 39(8): 1608-12, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8050307
18.
Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.
Thorax
; 50(12): 1301-4, 1995 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8553305
19.
Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.
Dig Dis Sci
; 42(11): 2304-9, 1997 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9398810
20.
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.
Ther Drug Monit
; 21(1): 63-73, 1999 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10051056